Product Description: β-Caryophyllene-d2 is deuterium labeled β-Caryophyllene. β-Caryophyllene is a CB2 receptor agonist.
Applications: COVID-19-immunoregulation
Formula: C15H22D2
References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94(1-2):1-12./[3]Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20(7):11808-29./[4]de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31.
CAS Number: 2006272-96-2
Molecular Weight: 206.36
Compound Purity: 94.22
Research Area: Cancer; Infection; Neurological Disease
Solubility: 10 mM in DMSO/DMSO : 50mg/mL (ultrasonic;warming;heat to 60°C)/Ethanol : ≥ 176.67mg/mL/H2O : 0.67mg/mL (ultrasonic)
Target: Cannabinoid Receptor;Endogenous Metabolite
Deutsch
English
